Objective: To identify social, demographic and clinical characteristics that influence survival of patients with systemic lupus erythematosus (SLE). Methods: Sixty-three patients with a diagnosis of SLE were studied at our medical services in 1999 and then reviewed in 2005. We utilized a protocol to obtain demographic and clinical traits, activity and damage indices, and health-related quality of life via the SF-36. All statistical tests were performed using a significance level of 5%. Results: Out of the 63 patients examined in 1999, six died, four were lost for the follow-up and the previous protocol was applied to the remaining 53 patients. The six patients who died presented the worst recorded health-related quality of fife, in all aspe...
Abstract Background Quality of life (QoL) is an important measure in health assessment. It is impact...
PURPOSE: To evaluate quality of life in Portuguese patients with Systemic Lupus Erithematosus (SLE)...
To investigate the role of clinical, immunological and psychological variables in influencing the he...
Objective: To identify social, demographic and clinical characteristics that influence survival of p...
To analyse the impact of systemic lupus erythematosus (SLE) on Portuguese patients’ quality of life
Objective. To determine whether quality of life in patients with systemic lupus erythematosus (SLE) ...
Objective. Having developed and validated a disease-specific health-related quality of life (HRQOL) ...
Objective: To determine disease activity in Systemic Lupus Erythematosus (SLE) patients and correlat...
Aim of the work: To study the clinical characteristics and health related quality of life (HRQoL) in...
Objective: To determine the quality of life of Systemic Lupus Erythematosus (SLE) patients attending...
AbstractLupus requires careful treatment by medical specialists. This study aimed to evaluate the qu...
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that affects any organs and syste...
ObjectiveThe Medical Outcomes Study Short Form 36 (SF?36) is recommended to assess quality of life (...
Purpose: We studied survival rate, prognostic factors, and causes of death in patients with systemic...
PURPOSE: We studied survival rate, prognostic factors, and causes of death in patients with systemic...
Abstract Background Quality of life (QoL) is an important measure in health assessment. It is impact...
PURPOSE: To evaluate quality of life in Portuguese patients with Systemic Lupus Erithematosus (SLE)...
To investigate the role of clinical, immunological and psychological variables in influencing the he...
Objective: To identify social, demographic and clinical characteristics that influence survival of p...
To analyse the impact of systemic lupus erythematosus (SLE) on Portuguese patients’ quality of life
Objective. To determine whether quality of life in patients with systemic lupus erythematosus (SLE) ...
Objective. Having developed and validated a disease-specific health-related quality of life (HRQOL) ...
Objective: To determine disease activity in Systemic Lupus Erythematosus (SLE) patients and correlat...
Aim of the work: To study the clinical characteristics and health related quality of life (HRQoL) in...
Objective: To determine the quality of life of Systemic Lupus Erythematosus (SLE) patients attending...
AbstractLupus requires careful treatment by medical specialists. This study aimed to evaluate the qu...
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that affects any organs and syste...
ObjectiveThe Medical Outcomes Study Short Form 36 (SF?36) is recommended to assess quality of life (...
Purpose: We studied survival rate, prognostic factors, and causes of death in patients with systemic...
PURPOSE: We studied survival rate, prognostic factors, and causes of death in patients with systemic...
Abstract Background Quality of life (QoL) is an important measure in health assessment. It is impact...
PURPOSE: To evaluate quality of life in Portuguese patients with Systemic Lupus Erithematosus (SLE)...
To investigate the role of clinical, immunological and psychological variables in influencing the he...